--- a
+++ b/clusters/9knumclustersv2/clust_1118.txt
@@ -0,0 +1,86 @@
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as prothrombin time (PT) or partial thromboplastin time (PTT) is within therapeutic range of intended use of anticoagulants
+Within  days of treatment initiation:\r\nActivated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (within  days of treatment initiation)
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (up to  days before treatment initiation)
+Within  days of treatment initiation:\r\nActivated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or partial thromboplastin time (PTT) is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+COHORT : Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+COHORT : Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+Within  (except as noted) days of planned treatment initiation: Activated partial thromboplastin time (aPTT) =< . x ULN unless patient is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) < . x ULN unless subject is receiving anticoagulant therapy, as long as partial thromboplastin time (PTT) is within therapeutic range of intended use of anticoagulants within  days of treatment initiation and must be independent of hematopoietic growth factor support
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants or patient has disseminated intravascular coagulation deemed by investigator to be due to leukemia, performed within  days of D of treatment under LCCC
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (performed within  days of treatment initiation)
+Activated partial thromboplastin time (aPTT) =< . X institutional ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of study registration
+Performed within  business days of treatment initiation with the exception of beta- HCG ( hours), if applicable: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants.
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Performed within  days of treatment initiation: Activated partial thromboplastin time (aPTT) ? . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, should be performed within  days of treatment initiation
+If not receiving anticoagulants: activated partial thromboplastin time (aPTT) =< . x ULN, performed within  days prior to day  of protocol therapy\r\n* If on anticoagulant therapy: aPTT must be within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment
+Activated partial thromboplastin time (aPTT) ? . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+Performed within  days of treatment initiation: activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Should be performed within  days of treatment initiation: activated partial thromboplastin time (aPTT) ? . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy; as long as PT or PTT is within therapeutic range of intended use of anticoagulants (performed within  days of treatment initiation)
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+To be performed within  days of treatment initiation: activated partial thromboplastin time (aPTT) ?. x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) ? . X ULN unless subject is receiving anticoagulant therapy as long as partial thromboplastin time (PTT) is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =<. X ULN unless subject is receiving anticoagulant therapy\r\nas long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Performed within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range on intended use of anticoagulants
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) ? . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Performed within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Performed within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of protocol registration
+Performed within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Determined within  weeks of treatment initiation: Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT and PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X institutional ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of registration
+To be performed within  business days prior to day : If not receiving anticoagulants: activated partial thromboplastin time (aPTT) =< . x ULN; if on anticoagulant therapy: aPTT must be within therapeutic range of intended use of anticoagulants
+Performed within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (performed within  days of registration)
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy, in which case, the partial thromboplastin time (PTT) should be within therapeutic range for intended use, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (within - days of treatment initiation)
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+International normalized ration (INR) or prothrombin time (PT) activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or aPTT is within therapeutic range of intended use of anticoagulants performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (performed within  days of treatment initiation)
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Performed  days prior to study registration up to the first dose of study drug: activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Within  days of treatment initiation: Activated partial thromboplastin Time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy; if subject receiving anticoagulants, PT or PTT should be within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin Time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy\r\nas long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (within  days of treatment initiation)
+Performed within  days prior to study registration up to the first dose of study drug: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, should be performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) ? . X ULN unless subject is receiving anticoagulant therapy as long as aPTT is within therapeutic range of intended within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as along as PT or PTT is within therapeutic range of intended use of anticoagulants (performed within  days of treatment initiation)
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless participant is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (within  days of treatment initiation)
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or aPTT is within therapeutic range of intended use of anticoagulants, should be performed within  days of treatment initiation, unless otherwise indicated
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days prior to registration
+Within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . X institutional ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (only if submitting to a biopsy), performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants within  days of treatment initiation
+Performed within  days of treatment initiation: Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy in which case the aPTT must be within the therapeutic range of intended use for the anticoagulant
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants (performed within  days of treatment initiation)
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . x ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of treatment initiation
+Activated partial thromboplastin time (aPTT) =< . X ULN unless subject is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of intended use of anticoagulants, performed within  days of protocol enrollment